American brain bank creates new hope for drug development at Lundbeck

Lundbeck is just one of many companies who have invested in the US-based Lieber Institute's brain bank. The industry hopes that the research done there can help to find new ways to tackle psychiatric disorders.
The US-based Lieber Institute has more than 3000 brains, and the hope is that the genetic information from them can help to generate the knowledge needed to achieve the next breakthrough within psychiatric disorders. | Foto: Rune Pedersen/Ritzau Scanpix
The US-based Lieber Institute has more than 3000 brains, and the hope is that the genetic information from them can help to generate the knowledge needed to achieve the next breakthrough within psychiatric disorders. | Foto: Rune Pedersen/Ritzau Scanpix

The Lieber Institute for Brain Development is far from the only academic institution that hosts a treasure trove of human brains, but the institute has attracted a lot of attention from the outside world and, not least, from the drug industry.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
  • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også